Azemiglitazone
Azemiglitazone Uses, Dosage, Side Effects, Food Interaction and all others data.
Azemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients).
Trade Name | Azemiglitazone |
Generic | Azemiglitazone |
Azemiglitazone Other Names | Azemiglitazone |
Type | |
Formula | C19H17NO5S |
Weight | Average: 371.41 Monoisotopic: 371.082743825 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Azemiglitazone